actigraph webinars
-
The Value Of Continuous Cough Monitoring And Its Impact On The Placebo Effect
5/9/2025
This presentation explores how digital health technologies are transforming the way persistent cough is monitored and understood across various respiratory diseases.
-
Accelerate Parkinson's Drug Development With Active, Passive DHT Monitoring
4/15/2025
Discover how a new ActiGraph–Indivi partnership is enhancing neurology clinical trials with digital health technologies that enable more sensitive, real-world outcome measures.
-
Modernizing Clinical Research With AI And Digital Data
3/7/2025
Discover how ActiGraph is revolutionizing clinical trials with patient-focused digital data and cutting-edge technology that enhances trial efficiency across all phases.
-
A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data
2/25/2025
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
-
Digital Physical Activity Measures In Phase 3 Immunology Trials
2/25/2025
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
-
Leveraging DHTs To Improve Data Collection And Analysis
2/25/2025
How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?
-
Accelerating DHT Research And Drug Development
12/19/2024
This presentation focuses on the scope and utility of the National Health and Nutrition Examination Survey, a program of studies designed to assess the health status of individuals in the United States.
-
Vital Sign Monitoring Using Wearable PPG Technology
11/20/2024
Explore the latest advancements in photoplethysmography (PPG) technology and discover how innovative cardiac metrics can enhance your research by joining the Q&A session with industry experts.
-
Addressing Opportunities And Challenges In Digital Health Data
10/22/2024
Experts from diverse industry sectors unpack key points from the FDA’s final guidance on Digital Health Technologies (DHT) for remote data collection in clinical investigations.
-
Measure Critical Health Outcomes In GLP-1 And Related Obesity Treatments
9/17/2024
In this session of Digital Health Monthly, Dr. Glenn Gaesser shares his extensive research on the intersection of obesity and exercise physiology, emphasizing the importance of physical activity.